The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kamala Jaju
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kamala Jaju, a promoter of Godavari Drugs Ltd, has acquired 3,00,000 convertible warrants through a preferential allotment on 18 March 2026. Before this, she held 9,10,000 equity shares representing 12.08% of the company. After the warrant acquisition, her total holding (shares + warrants) rises to 12,10,000, which works out to 8.99% of the expanded share capital and 9.69% on a fully diluted basis. The company's total equity share capital expanded from Rs. 7.53 crore to Rs. 10.13 crore following this preferential issue. The warrants, once exercised, will further increase her stake in the company.
This signals continued promoter confidence and commitment of fresh capital into the company. For shareholders, the preferential issue dilutes existing equity by about 34%, and the promoter's effective voting percentage drops on total capital basis (12.08% to 8.99%), though it strengthens her absolute economic interest on a diluted basis.